Crispr Therapeutics shares owned by Tower Research Capital
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Tower Research Capital
from 13F filings
Historical chart of Tower Research Capital investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Tower Research Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $4.2M | 65k | 64.81 |
| 2025-06-30 | $1.1M | 23k | 48.64 |
| 2025-03-31 | $829k | 24k | 34.02 |
| 2024-12-31 | $215k | 5.5k | 39.36 |
| 2024-09-30 | $43k | 909 | 46.98 |
| 2024-06-30 | $145k | 2.7k | 54.01 |
| 2024-03-31 | $302k | 4.4k | 68.16 |
| 2023-09-30 | $194k | 4.3k | 45.39 |
| 2023-06-30 | $770k | 14k | 56.14 |
| 2023-03-31 | $842k | 19k | 45.23 |
| 2022-12-31 | $138k | 3.4k | 40.63 |
| 2022-09-30 | $1.7M | 27k | 64.68 |
| 2022-06-30 | $1.1M | 18k | 60.77 |
| 2022-03-31 | $413k | 6.6k | 62.83 |
| 2021-12-31 | $234k | 3.1k | 75.83 |
| 2021-09-30 | $326k | 2.9k | 112.07 |
| 2021-06-30 | $2.0M | 12k | 161.92 |
| 2021-03-31 | $5.5M | 46k | 121.52 |
| 2020-12-31 | $533k | 3.3k | 161.29 |
| 2020-09-30 | $49k | 588 | 83.33 |
| 2020-06-30 | $18k | 243 | 74.07 |
| 2019-12-31 | $62k | 1.0k | 61.02 |
| 2019-09-30 | $2.0k | 47 | 42.55 |
| 2019-06-30 | $14k | 288 | 48.61 |
| 2019-03-31 | $41k | 1.1k | 35.71 |
| 2018-12-31 | $1.0M | 33k | 32.26 |
| 2018-09-30 | $49k | 1.5k | 33.33 |
| 2018-06-30 | $38k | 653 | 57.92 |
| 2018-03-31 | $116k | 2.5k | 45.81 |
| 2017-09-30 | $25k | 1.4k | 18.02 |
| 2016-12-31 | $10k | 479 | 20.88 |